Rosenberg Leon E
Department of Molecular Biology, Princeton University, Lewis Thomas Laboratory, Room 253, Princeton, NJ 08544, USA.
Med J Aust. 2002 Oct 7;177(7):368-71. doi: 10.5694/j.1326-5377.2002.tb04840.x.
The United States will invest nearly US$70 billion (US$260 per capita) on medical research this year, more than half of which will be sponsored by the biopharmaceutical industry. This investment has been shown to provide major gains in basic, disease-oriented and patient-oriented research. It also provides a huge economic return on investment--whether measured in terms of jobs created, health costs saved, or the dollar value of lives saved. Australia, whose investment in medical research is less than 10% that of the United States, should increase its national commitment.
美国今年将在医学研究上投入近700亿美元（人均260美元），其中一半以上将由生物制药行业赞助。事实证明，这笔投资在基础研究、疾病导向研究和患者导向研究方面都取得了重大成果。它还带来了巨大的经济投资回报——无论是从创造的就业机会、节省的医疗成本还是挽救生命的美元价值来衡量。澳大利亚在医学研究上的投资不到美国的10%，应该增加其国家投入。
